The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Samrat Pharmachem Ltd

Samrat Pharmachem Ltd

BSE 530125 · NSE SAMRATPH · ISIN INE103E01016 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹245.60

+1.01%

BSE close, 28 August 2026

Market cap

₹75.88 cr

0.3 cr shares · Micro cap

Free float

₹38.62 cr

as published

P/E · P/B

-34.4× · 1.09×

EPS ₹-7.14 · BV ₹225.32

FY25-26 rev / PAT

289.72 / -3.31

₹ cr, as filed

Filings, window

9

1 selected · 11%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹190.00 52-WK HIGH ₹333.00 ₹245.60 39% of range
Against 52-week high-26.2%
Against 52-week low+29.3%
Day change+1.01%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-7.14
Price / earnings-34.40×
Price / book1.09×
Book value — derived, price ÷ P/B₹225.32
Return on equity-3.18%
Operating margin2.37%
Net margin1.10%

Consistency check

P/B ÷ P/E, which must equal ROE
-3.17%
ROE as published
-3.18%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 79.76 0.88 2.84 2.37% 1.10%
Mar-26 · Q 71.77 -2.04 -6.59 -2.16% -2.84%
FY25-26 289.72 -3.31 -10.72 -0.45% -1.14%

Quarter on quarter

Revenue, quarter on quarter
+11.1%
Net profit, quarter on quarter
+143.1%
Operating margin, quarter on quarter
+453 bps

Disclosure profile 9 filings in the window

0 median 17.0 p75 · 25 sector max 52 9 11th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Selected sub-total1
Procedural
AGM / EGM3
Newspaper Publication2
Annual Report1
Auditor Appointment1
Book Closure1
Procedural sub-total8
Total9

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

9 filings · 1 selected · busiest 2026-08-27

Filing rhythm · the twelve most recent

2026-08-142026-09-24

SelectedProcedural

Filings

9 in the window · 6 earlier on record

  1. 24 September 2026 ·

    Auditor Appointment

    Appointment of Statutory Auditor/s

    The share holders of the company at the 34th AGM held on 23-09-2026, have approved the appointment of M/s. Divyesh J Shah & Associates, Chartered Accountants as Statutory Auditors of the ....

    Company Update / Appointment of Statutory Auditor/s View filing →

  2. 24 September 2026 ·

    AGM / EGM

    Scrutinizer's Report

    Scrutinizer's Report & Voting Results for 34th AGM

    AGM/EGM / AGM View filing →

  3. 23 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    The Company's 34th AGM was held on 23rd September 2026 and the business mentioned in the prior notice was transacted.

    AGM/EGM / AGM View filing →

  4. 2 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Notice of 34th AGM - Newspaper Publication

    Company Update / Newspaper Publication View filing →

  5. 27 August 2026 ·

    Book Closure

    Book Closure: Sunday, September 20, 2026 To Tuesday, September 22, 2026 (Both Days Inc lusive)

    The Register of Members and Share Transfer books will remain closed from September 20,2026 To September 22, 2026 (both days inclusive)

    Corp. Action / Book Closure View filing →

  6. 27 August 2026 ·

    AGM / EGM

    34Th Annual General Meeting Of Samrat Pharmachem Limited To Be Held On Wednesday, September 23, 2026

    34th Annual General Meeting of the company will be held on Wednesday, September 23, 2026 at 1:00 PM (IST) through Video Conferencing (VC) / Other Audio Video Means (OAVM)

    AGM/EGM / AGM View filing →

  7. 27 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    34th Annual Report for the Financial Year 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  8. 19 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication of extract of Standalone Unaudited Financial Results for the quarter ended June 30, 2026.

    Company Update / Newspaper Publication View filing →

  9. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held Today

    The Board considered and adopted the unaudited financial results for the quarter ended June 30, 2026

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Samrat Pharmachem Ltd · the 50 most recent filings